Medical Foods Market

Market Insights

Medical foods are specialized formulations intended as dietary supplements for specific diseases with unique nutritional needs that cannot be met with the usual dietary pattern. Medical foods are custom-made and administered enterally. The key market drivers assisting in the growth of the global medical food industry are the rising aging population, the shifting trend towards enteral nutrition, and the increasing demand for personalized medicine.

The report titled “Global Prenatal Medical Foods Market: Growth, Future Prospects, and Competitive Analysis, 2017–2025” offers strategic insights into the overall medical foods market, along with the market size and estimates for the duration of 2017 to 2025. The research study covers an in-depth analysis of market segments based on therapeutic type, application type, and different geographical regions.

The report also includes sections on the competitive profiling of the leading players in the global medical foods market, appealing investment propositions, and market positioning of key manufacturers to assist strategic decision-makers.

Geographically, the global medical foods market is studied for the following regional markets:

• North America
  • US.
  • Canada
• Europe
  • Germany
  • France
  • UK.
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • South-east Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC Countries
  • South Africa
  • Rest of the Middle East and Africa

The market size and forecast for these regional and country-level markets are presented in this study for the period 2015–2025. Market growth rates for the forecast period 2017–2025 are also included in this report, considering 2016 as the base year.

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for a better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges, and opportunities assists the readers in understanding the ongoing trends in the global medical foods market. Tools such as key player market positioning and appealing investment propositions provide readers with insights into the competitive landscape of the global medical foods market. This report concludes with a company profiles section that highlights major information about the key players engaged in the global medical food market. In-depth competitive environment analysis and historical year (2015) market size data are also provided in the report.

Thus, the research study provides a holistic view of the global medical foods market, offering market size and estimates for the period from 2017 to 2025, keeping in mind the above-mentioned factors.

Based on the type of therapeutic, the medical food market is segmented into:

• Pain Management
• Sleep Management
• Obesity and hypertension
• Cognitive Disorders
• Viral Infections
• Neuro-Degenerative Disorders
• Inborn Errors of Metabolism

Medical foods are a unique category of FDA-regulated products that meet the nutritional requirements or metabolic deficiencies of a particular disease condition. Medical foods are intended to affect the structure or function of the body, and thus the US FDA regulates medical foods as drugs. Medical food has a wide range of applicability in the treatment of different disease conditions.

However, for the purpose of the study, medical foods are segmented on the basis of therapeutic areas such as pain management, sleep management, obesity and hypertension, cognitive disorders, viral infections, neurodegenerative disorders, and inborn errors of metabolism. It is observed that, in the base year 2016, medical foods for inborn errors of metabolism held the largest market share because medical foods are the only recognized therapy for many inborn errors of metabolism identified on newborn screening. More than 3000 children are born in the United States each year which requires the use of medical foods. It is estimated that, due to the rising number of target populations and increasing demand for alternate therapies, medical foods for neurodegenerative disorders will show the fastest market growth during the forecast period.

Based on the type of application, the medical foods market is segmented into:

• Diabetic Neuropathy
• ADHD
• Depression
• Alzheimer’s Disease
• Nutritional Deficiency
• Others

Medical foods are defined under the Orphan Drug Act as “a food which is formulated to be consumed or administered under the supervision of a physician and which is intended for the specific dietary management of a disease or condition for which distinctive nutritional requirements, based on recognized scientific principles, are established by medical evaluation.” It mainly caters to managing nutritional needs that are associated with specific diseases or disorders.

The applications mentioned in the study include diabetic neuropathy, ADHD, depression, Alzheimer’s disease, nutritional deficiency, and others. Diabetes neuropathy accounts for a sizable portion of the global medical food market. According to the Centers for Disease Control and Prevention study, the prevalence of diabetes in the U.S. is approaching 10% and is rising by 5% per year. It is predicted that the number of people with diabetes worldwide will double between 2000 and 2030, almost reaching a pandemic level of 366 million people. The fastest-growing segment is Alzheimer’s disease in the global medical foods market for the forecast period of 2017–2025 due to the rising incidence of Alzheimer’s disease.

For the purpose of this study, the global medical foods market is categorized as follows:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

For the purpose of this study, the global medical foods market is segmented into six regional markets: North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. In the base year 2016, North America dominated the global medical foods market, which was followed by Europe.

The key market drivers assisting in the growth of the North American medical food industry comprise the rise in the aging population, the shifting trend towards enteral nutrition, and the increasing demand for personalized medicine. Thus, the North American medical food market is expected to maintain its growth throughout the forecast period due to increasing support from nutritionists and physicians as a supplement to drug treatment. Asia Pacific is expected to be the fastest-growing region due to the growing acceptance of supplements and enteral nutrition. Moreover, the large population of people with diseases such as diabetes and age-related disorders in the region is further fueling market growth in the Asia Pacific.

Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions

Chapter 2 Executive Summary
2.1 Medical Foods Market Portraiture
2.2 Medical Foods Market, by Therapeutic Type, 2016 (US$ Mn)
2.3 Medical Foods Market, by Application Type, 2016 (US$ Mn)
2.4 Medical Foods Market, by Geography, 2016 (Value %)

Chapter 3 Global Medical Foods Market Analysis
3.1 Global Medical Foods Market Overview
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.1.1 Growing Demand for Personalized Medicine
3.2.1.2 Significant Growth in Geriatric Population
3.2.1.3 Growing Preference to Enteral Nutrition
3.2.2 Challenges
3.2.3 Opportunities
3.3 Attractive Investment Proposition
3.4 Competitive Analysis: Global Medical Foods Market, 2016 (Value %)

Chapter 4 Global Medical Foods Market Analysis, By Therapeutic Type
4.1 Overview
4.1.1 Market Attractive Proposition of Medical Foods Market, by Therapeutic Type, 2016
4.2 Pain Management
4.3 Sleep Management
4.4 Obesity and Hypertension
4.5 Cognitive Disorders
4.6 Viral Infections
4.7 Neuro-Degenerative Disorders
4.8 Inborn Errors of Metabolism

Chapter 5 Global Medical Foods Market Analysis, By Application Type
5.1 Overview
5.1.1 Market Attractive Proposition of Medical Foods Market, by Application Type, 2016
5.2 Diabetic Neuropathy
5.3 ADHD
5.4 Depression
5.5 Alzheimer’s Disease
5.6 Nutritional Deficiency
5.7 Others

Chapter 6 Global Medical Foods Market, By Geography
6.1 Preface
6.2 North America (U.S. & Canada)
6.2.1 North America Medical Foods Market, by Therapeutic Type, 2015-2025 (US$ Mn)
6.2.2 North America Medical Foods Market, by Application Type, 2015-2025 (US$ Mn)
6.2.3 North America Medical Foods Market, by Country, 2015 – 2025 (US$ Mn)
6.3 Europe (U.K., Germany & Rest of Europe)
6.3.1 Europe Medical Foods Market, by Therapeutic Type, 2015-2025 (US$ Mn)
6.3.2 Europe Medical Foods Market, by Application Type, 2015-2025 (US$ Mn)
6.3.3 Europe Medical Foods Market, by Country, 2015 – 2025 (US$ Mn)
6.4 Asia-Pacific (China, Japan & Rest of Asia-Pacific)
6.4.1 Asia Pacific Medical Foods Market, by Therapeutic Type, 2015-2025 (US$ Mn)
6.4.2 Asia Pacific Medical Foods Market, by Application Type, 2015-2025 (US$ Mn)
6.4.3 Asia – Pacific Medical Foods Market, by Country, 2015 – 2025 (US$ Mn)
6.5 Latin America (Brazil, Mexico and Rest of LATAM)
6.5.1 Latin America Medical Foods Market, by Therapeutic Type, 2015-2025 (US$ Mn)
6.5.2 Latin America Medical Foods Market, by Application Type, 2015-2025 (US$ Mn)
6.5.3 Latin America Medical Foods Market, by Country, 2015 – 2025 (US$ Mn)
6.6 Middle East and Africa
6.6.1 Middle East and Africa Medical Foods Market, by Therapeutic Type, 20152025 (US$ Mn)
6.6.2 Middle East and Africa Medical Foods Market, by Application Type, 2015-
2025 (US$ Mn)
6.6.3 Middle East and Africa Applications Market, by Country, 2015 – 2025 (US$ Mn)

Chapter 7 Company Profiles 7.1 Abbott Laboratories
7.2 Nestle S.A.
7.3 Danone S.A
7.4 Primus Pharmaceuticals, Inc.
7.5 Fresenius Kabi AG
7.6 Metagenics, Inc.
7.7 Mead Johnson & Company, LLC
7.8 MicroBiome Therapeutics LLC
7.9 Proliant Health and Biologicals (a division of Proliant, Inc.)
7.10 Entera Health, Inc.
7.11 Valeant Pharmaceuticals
7.12 Vaya Pharma, Inc. USA
7.13 Upsher-Smith Laboratories, LLC
7.14 Physician Therapeutics, LLC

List of Figures

FIG. 1 Medical Foods Market: Research Methodology
FIG. 2 Medical Foods Market, by Therapeutic Type, 2016 (US$ Mn)
FIG. 3 Medical Foods Market, by Application Type, 2016 (US$ Mn)
FIG. 4 Medical Foods Market, by Geography, 2016 (Value %)
FIG. 5 Attractive Investment Proposition
FIG. 6 Competitive Analysis: Global Medical Foods Market, 2016 (Value %)
FIG. 7 Global Pain Management Market(US$ Mn), 2015-2025
FIG. 8 Global Sleep Management Market(US$ Mn), 2015-2025
FIG. 9 Global Obesity and Hypertension Market (US$ Mn), 2015-2025
FIG. 10 Global Cognitive Disorders Market (US$ Mn), 2015-2025
FIG. 11 Global Viral Infections Market (US$ Mn), 2015-2025
FIG. 12 Global Neuro-Degenerative Disorders Market(US$ Mn), 2015-2025
FIG. 13 Global Inborn Errors of Metabolism Market (US$ Mn), 2015-2025
FIG. 14 Global Diabetic Neuropathy Market(US$ Mn), 2015-2025
FIG. 15 Global ADHD Market(US$ Mn), 2015-2025
FIG. 16 Global Depression Market (US$ Mn), 2015-2025
FIG. 17 Global Alzheimer’s Disease Market (US$ Mn), 2015-2025
FIG. 18 Global Nutritional Deficiency Market (US$ Mn), 2015-2025
FIG. 19 Global Others Applications Market(US$ Mn), 2015-2025

List of Tables

TABLE 1 Global Medical Foods Market, By Therapeutic Type (US$ Mn), 2015– 2025 (Value)
TABLE 2 Global Medical Foods Market, By Application Type (US$ Mn), 2015– 2025 (Value)
TABLE 3 Global Medical Foods Market, by Geography, 2015 – 2025 (US$ Mn)
TABLE 4 North America Medical Foods Market, by Therapeutic Type, 2015 – 2025 (US$ Mn)
TABLE 5 North America Medical Foods Market, by Application Type, 2015 – 2025 (US$ Mn)
TABLE 6 North America Medical Foods Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 7 Europe Medical Foods Market, by Therapeutic Type, 2015 – 2025 (US$ Mn)
TABLE 8 Europe Medical Foods Market, by Application Type, 2015 – 2025 (US$ Mn)
TABLE 9 Europe Medical Foods Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 10 Asia Pacific Medical Foods Market, by Therapeutic Type, 2015 – 2025 (US$ Mn)
TABLE 11 Asia Pacific Medical Foods Market, by Application Type, 2015 – 2025 (US$ Mn)
TABLE 12 Asia – Pacific Medical Foods Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 13 Latin America Medical Foods Market, by Therapeutic Type, 2015 – 2025 (US$ Mn)
TABLE 14 Latin America Medical Foods Market, by Application Type, 2015 – 2025 (US$ Mn)
TABLE 15 Latin America Medical Foods Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 16 Middle East and Africa Medical Foods Market, by Therapeutic Type, 2015 – 2025 (US$
Mn)
TABLE 17 Middle East and Africa Medical Foods Market, by Applications Type, 2015 – 2025 (US$
Mn)
TABLE 18 Middle East and Africa Applications Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 19 Abbott Laboratories: Company Snapshot (Business Description; Financial Performance;
Product Position/Portfolio; News Coverage)
TABLE 20 Nestle S.A.: Company Snapshot (Business Description; Financial Performance; Product
Position/Portfolio; News Coverage)
TABLE 21 Danone S.A: Company Snapshot (Business Description; Financial Performance; Product
Position/Portfolio; News Coverage)
TABLE 22 Primus Pharmaceuticals, Inc.: Company Snapshot (Business Description; Financial
Performance; Product Position/Portfolio; News Coverage)
TABLE 23 Fresenius Kabi AG: Company Snapshot (Business Description; Financial Performance;
Product Position/Portfolio; News Coverage)
TABLE 24 Metagenics, Inc.: Company Snapshot (Business Description; Financial Performance;
Product Position/Portfolio; News Coverage)
TABLE 25 Mead Johnson & Company, LLC: Company Snapshot (Business Description; Financial
Performance; Product Position/Portfolio; News Coverage)
TABLE 26 MicroBiome Therapeutics LLC: Company Snapshot (Business Description; Financial
Performance; Product Position/Portfolio; News Coverage)
TABLE 27 Proliant Health and Biologicals (a division of Proliant, Inc.): Company Snapshot (Business
Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 28 Entera Health, Inc.: Company Snapshot (Business Description; Financial Performance;
Product Position/Portfolio; News Coverage)
TABLE 29 Valeant Pharmaceuticals: Company Snapshot (Business Description; Financial
Performance; Product Position/Portfolio; News Coverage)
TABLE 30 Vaya Pharma, Inc. USA: Company Snapshot (Business Description; Financial
Performance; Product Position/Portfolio; News Coverage)
TABLE 31 Upsher-Smith Laboratories, LLC: Company Snapshot (Business Description; Financial
Performance; Product Position/Portfolio; News Coverage)
TABLE 32 Physician Therapeutics, LLC: Company Snapshot (Business Description; Financial
Performance; Product Position/Portfolio; News Coverage)